These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1752526)

  • 1. [Clinical use of hematopoietic growth factors].
    Gianni AM; Bregni M; Siena S; Tarella C; DiNicola M; Bonadonna G
    Haematologica; 1991 Jun; 76 Suppl 3():3-10. PubMed ID: 1752526
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotherapy in hematology: the next decade.
    Quesenberry PJ
    Rev Invest Clin; 1994 Apr; Suppl():8-15. PubMed ID: 7886315
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
    Ganser A; Ottmann OG; Hoelzer D
    Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of hematopoietic growth factors.
    Löwenberg B; Dale DC; Sheridan WP
    Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
    [No Abstract]   [Full Text] [Related]  

  • 5. [The application of hematopoietic growth factors in oncology].
    Hoekman K; Wagstaff J; Ossenkoppele GJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):409-14. PubMed ID: 2020312
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factors in the management of adult acute leukemia.
    Bernstein SH
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):255-74. PubMed ID: 8449861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supernatant of human umbilical vein endothelial cell culture can favour in vivo neutropoiesis.
    Ghezzo F; Garbarino G; Osella D; Romano S; Dolcetti A; Pegoraro L; Emanuelli G
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):385-9. PubMed ID: 1670040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.
    Demetri GD
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):233-49. PubMed ID: 8150782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
    Siena S; Bregni M; Bonsi L; Strippoli P; Peccatori F; Magni M; Di Nicola M; Bagnara GP; Massimo Gianni A
    Stem Cells; 1993 Jul; 11 Suppl 2():72-5. PubMed ID: 8104618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is blood or bone marrow better?
    Kessinger A
    Stem Cells; 1993 Jul; 11(4):290-5. PubMed ID: 8104616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioprotection and therapy of radiation injury with cytokines.
    Neta R
    Prog Clin Biol Res; 1990; 352():471-8. PubMed ID: 2205873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The present and future of hematopoietic cytokines in clinical practice.
    George MJ
    Stem Cells; 1994; 12 Suppl 1():249-55. PubMed ID: 7696964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is our current strategy in manipulating hemopoiesis in autologous transplantation correct?
    To LB
    Stem Cells; 1993 Jul; 11(4):283-9. PubMed ID: 8104615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The protective action of a thymus extract on hematopoiesis in patients treated with intense radiation and cytostatic therapy].
    Orecchia C; Ardizzone L; Sigaudo F
    Minerva Med; 1970 Sep; 61(72):3825-36. PubMed ID: 5454451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of hematopoietic growth factors in treatment of bone marrow failure].
    Robak T; Krykowski E
    Pol Arch Med Wewn; 1994 Jul; 92(1):1-8. PubMed ID: 7971472
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy-induced myelosuppression.
    Maxwell MB; Maher KE
    Semin Oncol Nurs; 1992 May; 8(2):113-23. PubMed ID: 1621002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of hematopoietic growth factors.
    Steward WP; Scarffe JH; Dexter TM; Testa NG
    Immunol Ser; 1990; 49():359-78. PubMed ID: 2090257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies.
    Koumakis G; Vassilomanolakis M; Hatzichristou H; Barbounis V; Filis J; Papanastasiou K; Moraki M; Kritsioti M; Plataniotis G; Stamatelou M; Efremidis AP
    Bone Marrow Transplant; 1996 Dec; 18(6):1065-72. PubMed ID: 8971374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma.
    Canellos GP
    Ann Oncol; 1994; 5 Suppl 2():121-2. PubMed ID: 8204512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.